CYMAT TECHNOLOGIES LTD (CYM.CA) Stock Fundamental Analysis

TSX-V:CYM • CA23257A2083

0.1 CAD
0 (0%)
Last: Feb 13, 2026, 07:00 PM
Fundamental Rating

0

CYM gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 800 industry peers in the Metals & Mining industry. Both the profitability and financial health of CYM have multiple concerns. CYM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CYM has reported negative net income.
  • CYM had a negative operating cash flow in the past year.
  • In the past 5 years CYM always reported negative net income.
  • In the past 5 years CYM reported 4 times negative operating cash flow.
CYM.CA Yearly Net Income VS EBIT VS OCF VS FCFCYM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -110.54%, CYM is doing worse than 75.25% of the companies in the same industry.
Industry RankSector Rank
ROA -110.54%
ROE N/A
ROIC N/A
ROA(3y)-125.07%
ROA(5y)-92.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYM.CA Yearly ROA, ROE, ROICCYM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • CYM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYM.CA Yearly Profit, Operating, Gross MarginsCYM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

0

2. Health

2.1 Basic Checks

  • CYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CYM has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CYM has been increased compared to 5 years ago.
  • CYM has a worse debt/assets ratio than last year.
CYM.CA Yearly Shares OutstandingCYM.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CYM.CA Yearly Total Debt VS Total AssetsCYM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

  • Based on the Altman-Z score of -40.69, we must say that CYM is in the distress zone and has some risk of bankruptcy.
  • CYM has a worse Altman-Z score (-40.69) than 79.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -40.69
ROIC/WACCN/A
WACC9.8%
CYM.CA Yearly LT Debt VS Equity VS FCFCYM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M -4M

2.3 Liquidity

  • CYM has a Current Ratio of 0.86. This is a bad value and indicates that CYM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CYM has a Current ratio of 0.86. This is in the lower half of the industry: CYM underperforms 63.88% of its industry peers.
  • CYM has a Quick Ratio of 0.86. This is a bad value and indicates that CYM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.49, CYM is doing worse than 69.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.49
CYM.CA Yearly Current Assets VS Current LiabilitesCYM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

1

3. Growth

3.1 Past

  • CYM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.62%.
  • Looking at the last year, CYM shows a very negative growth in Revenue. The Revenue has decreased by -34.48% in the last year.
  • CYM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.07% yearly.
EPS 1Y (TTM)-7.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)-34.48%
Revenue growth 3Y5.91%
Revenue growth 5Y17.07%
Sales Q2Q%-24.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYM.CA Yearly Revenue VS EstimatesCYM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CYM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYM.CA Price Earnings VS Forward Price EarningsCYM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYM.CA Per share dataCYM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • CYM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CYMAT TECHNOLOGIES LTD

TSX-V:CYM (2/13/2026, 7:00:00 PM)

0.1

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)12-30
Earnings (Next)03-30
Inst Owners0.06%
Inst Owner ChangeN/A
Ins Owners4.48%
Ins Owner ChangeN/A
Market Cap10.03M
Revenue(TTM)1.83M
Net Income(TTM)-4.06M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.48
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.02
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -110.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-125.07%
ROA(5y)-92.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.68%
Cap/Sales 1.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.49
Altman-Z -40.69
F-Score2
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)72.01%
Cap/Depr(5y)71.09%
Cap/Sales(3y)12.2%
Cap/Sales(5y)8.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.48%
Revenue growth 3Y5.91%
Revenue growth 5Y17.07%
Sales Q2Q%-24.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.18%
OCF growth 3YN/A
OCF growth 5YN/A

CYMAT TECHNOLOGIES LTD / CYM.CA FAQ

What is the ChartMill fundamental rating of CYMAT TECHNOLOGIES LTD (CYM.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to CYM.CA.


Can you provide the valuation status for CYMAT TECHNOLOGIES LTD?

ChartMill assigns a valuation rating of 0 / 10 to CYMAT TECHNOLOGIES LTD (CYM.CA). This can be considered as Overvalued.


What is the profitability of CYM stock?

CYMAT TECHNOLOGIES LTD (CYM.CA) has a profitability rating of 0 / 10.


What is the financial health of CYMAT TECHNOLOGIES LTD (CYM.CA) stock?

The financial health rating of CYMAT TECHNOLOGIES LTD (CYM.CA) is 0 / 10.